Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: An exception to the norm

被引:179
作者
Ahmed, Nuzhat
Thompson, Erik W.
Quinn, Michael A.
机构
[1] Royal Hosp Women, Womens Canc Res Ctr, Melbourne, Vic 3053, Australia
[2] Univ Melbourne, Dept Surg, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia
[4] St Vincents Inst Med Res, VBCRC Invas & Metatasis Unit, Melbourne, Vic, Australia
关键词
D O I
10.1002/jcp.21240
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cancer that arises from the ovarian surface epithelium (OSE) accounts for approximately 90% of human ovarian cancer, and is the fourth leading cause of cancer-related deaths among women in developed countries. The pathophysiology of epithelial ovarian cancer is still unclear because of the poor understanding of the complex nature of its development and the unusual mechanism(s) of disease progression. Recent studies have reported epithelial-mesenchymal transition (EMT) in cultured OSE and ovarian cancer cell lines in response to various stimuli, but our understanding of the importance of these observations for normal ovarian physiology and cancer progression is not well established. This review highlights the current literature on EMT-associated events in normal OSE and ovarian cancer cell lines, and discusses its implication for normal ovarian function as well as acquisition of neoplastic phenotypes. The pathological changes in OSE in response to EMT during neoplastic transformation and the contribution of hormones, growth factors, and cytokines that initiate and drive EMT to sustain normal ovarian function, as well as cancer development and progression are also discussed. Finally, emphasis is placed on the clinical implications of EMT and potential therapeutic opportunities that may arise from these observations have been proposed.
引用
收藏
页码:581 / 588
页数:8
相关论文
共 84 条
[1]   Ascites induces modulation of α6β1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma [J].
Ahmed, N ;
Riley, C ;
Oliva, K ;
Rice, G ;
Quinn, M .
BRITISH JOURNAL OF CANCER, 2005, 92 (08) :1475-1485
[2]   Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium [J].
Ahmed, N ;
Maines-Bandiera, S ;
Quinn, MA ;
Unger, WG ;
Dedhar, S ;
Auersperg, N .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 290 (06) :C1532-C1542
[3]   Ovarian surface epithelium: Biology, endocrinology, and pathology [J].
Auersperg, N ;
Wong, AST ;
Choi, KC ;
Kang, SK ;
Leung, PCK .
ENDOCRINE REVIEWS, 2001, 22 (02) :255-288
[4]   EXPRESSION OF 2 MUCIN ANTIGENS IN CULTURED HUMAN OVARIAN SURFACE EPITHELIUM - INFLUENCE OF A FAMILY HISTORY OF OVARIAN-CANCER [J].
AUERSPERG, N ;
MAINESBANDIERA, S ;
BOOTH, JH ;
LYNCH, HT ;
GODWIN, AK ;
HAMILTON, TC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (02) :558-565
[5]  
Bagnato A, 1999, CANCER RES, V59, P720
[6]  
Behrens J, 1992, Semin Cell Biol, V3, P169
[7]   REGULATION OF GROWTH OF NORMAL OVARIAN EPITHELIAL-CELLS AND OVARIAN-CANCER CELL-LINES BY TRANSFORMING GROWTH-FACTOR-BETA [J].
BERCHUCK, A ;
RODRIGUEZ, G ;
OLT, G ;
WHITAKER, R ;
BOENTE, MP ;
ARRICK, BA ;
CLARKEPEARSON, DL ;
BAST, RC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (02) :676-684
[8]   Disaggregation and invasion of ovarian carcinoma ascites spheroids [J].
Burleson, KM ;
Boente, MP ;
Pambuccian, SE ;
Skubitz, APN .
JOURNAL OF TRANSLATIONAL MEDICINE, 2006, 4 (1)
[9]   Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: Role of fibroblast growth factor receptor-2 [J].
Chaffer, Christine L. ;
Brennan, Janelle P. ;
Slavin, John L. ;
Blick, Tony ;
Thompson, Erik W. ;
Williams, Elizabeth D. .
CANCER RESEARCH, 2006, 66 (23) :11271-11278
[10]   Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells [J].
Choi, JH ;
Choi, KC ;
Auersperg, N ;
Leung, PCK .
CANCER RESEARCH, 2006, 66 (07) :3912-3920